false
Catalog
EA SUD/OUD 101 & Brain Science of Addiction
Slides
Slides
Back to course
Pdf Summary
The document outlines the initiatives of the Opioid Response Network (ORN), funded by the Substance Abuse and Mental Health Services Administration (SAMHSA), to combat the opioid and stimulant crisis in the U.S. ORN offers technical assistance and resources to states, tribes, organizations, and individuals to support evidence-based prevention, treatment, recovery, and harm reduction of substance use disorders. The network deploys local consultants specialized in these areas to aid communities in need.<br /><br />ORN's mission is to enhance prevention and treatment strategies, especially when it comes to medications like buprenorphine, naltrexone, and methadone, and to provide recovery support across the country. They focus on building upon existing efforts and filling gaps in addiction treatment without duplicating efforts.<br /><br />The document provides a comprehensive understanding of addiction from various perspectives including personal responsibility, the addictive nature of drugs, societal influences, and as a brain disease described by the American Society of Addiction Medicine (ASAM). The document details the pharmacological criteria for diagnosing substance use disorders using the DSM-5 criteria, such as impaired control, social impairment, risky use, tolerance, and withdrawal symptoms.<br /><br />It also discusses the dangers of opioids, including fentanyl, and the method of counteracting overdose with naloxone. Additionally, it highlights the increasing threat of xylazine, a veterinary tranquilizer, in street drug supplies.<br /><br />The document further reviews methamphetamine use, with emphasis on its rising potency, short-term and long-term effects, and its interaction with opioids, particularly in what's termed the "Fourth Wave" of drug use where methamphetamine and fentanyl are increasingly used together, posing heightened overdose risks.<br /><br />The document concludes with questions for reflection on addiction perspectives and responsibilities related to opioid use disorders.
Keywords
Opioid Response Network
SAMHSA
substance use disorders
harm reduction
buprenorphine
naltrexone
methadone
fentanyl
naloxone
xylazine
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English